Somerville, NJ-Ethicon Products, a division of Ethicon, Inc., has received FDA approval to market the Vicryl Plus Antibacterial Suture, which uses an antibacterial agent designed to reduce bacterial colonization on the suture. The antibacterial agent, triclosan (Irgacare MP), is known to be effective against Staphylococcus aureus, S epidermidis, and methicillin-resistant strains of Staphylococcus.
